Healthcare provider profile · identity verified

Rafael Ubeda, MD

Family Practice · LAKE WORTH, FL · NPI 1699724005

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	957	293
Losartan Potassium	Losartan Potassium	561	157
Metformin Hcl	Metformin Hcl	536	156
Gabapentin	Gabapentin	514	137
Levothyroxine Sodium	Levothyroxine Sodium	496	107
Alcohol Prep Pads	Alcohol Antiseptic Pads	373	61
Lisinopril	Lisinopril	367	100
Tamsulosin Hcl	Tamsulosin Hcl	356	90
Amlodipine Besylate	Amlodipine Besylate	333	98
Famotidine	Famotidine	293	87
Hydrochlorothiazide	Hydrochlorothiazide	293	78
Omeprazole	Omeprazole	291	80
Simvastatin	Simvastatin	231	62
Rosuvastatin Calcium	Rosuvastatin Calcium	228	66
Glipizide	Glipizide	223	60
Pantoprazole Sodium	Pantoprazole Sodium	217	57
Metoprolol Tartrate	Metoprolol Tartrate	187	40
Eliquis	Apixaban	186	37
Metoprolol Succinate	Metoprolol Succinate	172	41
Diclofenac Sodium	Diclofenac Sodium	160	32
Furosemide	Furosemide	156	44
Clopidogrel	Clopidogrel Bisulfate	150	38
Albuterol Sulfate Hfa	Albuterol Sulfate	149	38
Carvedilol	Carvedilol	147	36
Finasteride	Finasteride	140	38
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	139	24
Montelukast Sodium	Montelukast Sodium	135	33
Ammonium Lactate	Ammonium Lactate	127	20
Ssd	Silver Sulfadiazine	126	24
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	125	42
Allopurinol	Allopurinol	120	27
Folic Acid	Folic Acid	109	33
Azithromycin	Azithromycin	103	83
Memantine Hcl	Memantine Hcl	102	17
Vitamin D2	Ergocalciferol (Vitamin D2)	95	32
Sildenafil Citrate	Sildenafil Citrate	94	29
Fluticasone Propionate	Fluticasone Propionate	89	30
Tizanidine Hcl	Tizanidine Hcl	87	40
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	84	27
Nifedipine Er	Nifedipine	83	24
Ketoconazole	Ketoconazole	81	14
Alendronate Sodium	Alendronate Sodium	80	24
Comfort Ez Pen Needle	Pen Needle, Diabetic	80	16
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	77	18
Escitalopram Oxalate	Escitalopram Oxalate	76	27
Quetiapine Fumarate	Quetiapine Fumarate	74	16
Donepezil Hcl	Donepezil Hcl	70	20
Trazodone Hcl	Trazodone Hcl	63	21
Farxiga	Dapagliflozin Propanediol	60	15
Lactulose	Lactulose	59	15
Jardiance	Empagliflozin	58	15
Lantus	Insulin Glargine,hum.Rec.Anlog	57	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	55	15
Glimepiride	Glimepiride	51	16
Megestrol Acetate	Megestrol Acetate	51	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	50	17
Ezetimibe	Ezetimibe	48	12
Atenolol	Atenolol	46	15
Mirtazapine	Mirtazapine	46	12
Buspirone Hcl	Buspirone Hcl	45	12
Fenofibrate	Fenofibrate	45	13
Januvia	Sitagliptin Phosphate	43	suppressed
Naproxen	Naproxen	43	17
Advair Hfa	Fluticasone Propion/Salmeterol	41	suppressed
Tradjenta	Linagliptin	41	suppressed
Meloxicam	Meloxicam	40	23
Lorazepam	Lorazepam	38	suppressed
Mupirocin	Mupirocin	38	22
Silver Sulfadiazine	Silver Sulfadiazine	38	suppressed
Citalopram Hbr	Citalopram Hydrobromide	37	suppressed
Clobetasol Propionate	Clobetasol Propionate	37	11
Glipizide Er	Glipizide	37	13
Meclizine Hcl	Meclizine Hcl	37	22
Sertraline Hcl	Sertraline Hcl	37	12
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	35	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	31
Ibuprofen	Ibuprofen	33	23
Clonidine Hcl	Clonidine Hcl	32	suppressed
Enalapril Maleate	Enalapril Maleate	32	suppressed
Hydralazine Hcl	Hydralazine Hcl	32	suppressed
Tadalafil	Tadalafil	31	suppressed
Levetiracetam	Levetiracetam	30	suppressed
Symbicort	Budesonide/Formoterol Fumarate	30	suppressed
Entresto	Sacubitril/Valsartan	29	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	29	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Latanoprost	Latanoprost	27	suppressed
Cilostazol	Cilostazol	26	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	25	suppressed
Irbesartan	Irbesartan	25	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	suppressed
Pravastatin Sodium	Pravastatin Sodium	24	suppressed
Single Use Swab	Alcohol Antiseptic Pads	24	13
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	24	11
Chlorthalidone	Chlorthalidone	23	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Levofloxacin	Levofloxacin	22	20
Baclofen	Baclofen	21	15
Brilinta	Ticagrelor	21	suppressed
Constulose	Lactulose	21	suppressed
Metronidazole	Metronidazole	21	15
Prednisone	Prednisone	21	suppressed
Hydrocortisone	Hydrocortisone	20	suppressed
Olanzapine	Olanzapine	20	suppressed
Temazepam	Temazepam	20	suppressed
Tresiba Flextouch U-100	Insulin Degludec	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Divalproex Sodium	Divalproex Sodium	19	suppressed
Duloxetine Hcl	Duloxetine Hcl	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Linzess	Linaclotide	19	suppressed
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	19	15
Amoxicillin	Amoxicillin	18	17
Ciclopirox	Ciclopirox	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Bumetanide	Bumetanide	17	suppressed
Comfort Ez Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	17	suppressed
Nystatin	Nystatin	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Dutasteride	Dutasteride	16	suppressed
Isibloom	Desogestrel-Ethinyl Estradiol	16	suppressed
Lacosamide	Lacosamide	16	suppressed
Ozempic	Semaglutide	16	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Celecoxib	Celecoxib	15	suppressed
Permethrin	Permethrin	15	suppressed
Levemir Flexpen	Insulin Detemir	14	suppressed
Nystop	Nystatin	14	suppressed
Calcitriol	Calcitriol	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	12
Risperidone	Risperidone	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Aptiom	Eslicarbazepine Acetate	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Potassium Chloride	Potassium Chloride	12	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	11	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Lumigan	Bimatoprost	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Mesalamine	Mesalamine	11	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	11	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Procto-Med Hc	Hydrocortisone	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error